Exeter Financial LLC Increases Stock Position in The Clorox Company (NYSE:CLX)

Exeter Financial LLC boosted its holdings in shares of The Clorox Company (NYSE:CLX) by 2.6% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 7,986 shares of the company’s stock after acquiring an additional 199 shares during the quarter. Exeter Financial LLC’s holdings in Clorox were worth $1,297,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Prospera Private Wealth LLC purchased a new stake in shares of Clorox during the 3rd quarter worth $27,000. Continuum Advisory LLC lifted its position in shares of Clorox by 300.0% during the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after buying an additional 138 shares during the last quarter. Quarry LP boosted its holdings in shares of Clorox by 99.1% in the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after buying an additional 114 shares in the last quarter. Carolina Wealth Advisors LLC purchased a new position in shares of Clorox in the 3rd quarter worth approximately $48,000. Finally, Friedenthal Financial bought a new position in shares of Clorox during the 3rd quarter worth approximately $49,000. Institutional investors own 78.53% of the company’s stock.

Clorox Trading Down 0.2 %

NYSE CLX opened at $157.32 on Tuesday. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The company has a market capitalization of $19.47 billion, a PE ratio of 54.82, a P/E/G ratio of 3.04 and a beta of 0.42. The company has a fifty day moving average of $164.55 and a 200 day moving average of $156.00.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The business had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same quarter in the previous year, the firm posted $0.49 EPS. The company’s revenue for the quarter was up 27.0% on a year-over-year basis. Research analysts forecast that The Clorox Company will post 6.85 earnings per share for the current year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be given a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 annualized dividend and a yield of 3.10%. Clorox’s dividend payout ratio is presently 170.03%.

Analysts Set New Price Targets

Several equities analysts have issued reports on CLX shares. Wells Fargo & Company raised shares of Clorox from an “underweight” rating to an “equal weight” rating and lifted their price target for the stock from $155.00 to $157.00 in a report on Tuesday, January 7th. DA Davidson upped their target price on Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a research report on Monday, November 4th. StockNews.com downgraded Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Evercore ISI cut their price objective on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a report on Monday, October 14th. Finally, JPMorgan Chase & Co. lifted their target price on shares of Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a research note on Friday, October 11th. Four investment analysts have rated the stock with a sell rating, ten have issued a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $157.46.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.